Optical molecular imaging in oral-and oropharyngeal squamous cell carcinoma using a novel uPAR-targeting near-infrared imaging agent FG001 - An explorative phase II clinical trial
Favorite
Share
More Options
16

Open in WPS to view all 16 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
